Could Dynamic Duo Diageo plc And GlaxoSmithKline plc Make You A Millionaire?

GlaxoSmithKline plc (LON: GSK) and Diageo plc (LON: DGE) are the perfect shares to get rich slowly.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The £1m mark is a key goal for many investors and the most effective way to hit this target is slowly, without taking excessive risks. Personally, I think the best investments to help you do this are GlaxoSmithKline (LSE: GSK) and Diageo (LSE: DGE). 

Glaxo and Diageo won’t run you into Warren Buffett overnight, but they will help you meet your savings goals. Indeed, his first rule of investing is “don’t lose money”, the second rule is “don’t forget rule one”. Losing money can be extremely damaging to you investment returns and even a small 10% loss can hold you back for years.

And neither Glaxo nor Diageo will cost you money. Their shares may fall in the short term but over the long term they should push steadily higher.

Defensive companies

You see, Diageo and Glaxo are defensive companies. Diageo is the world’s largest alcoholic beverage company, with some of the world’s bestselling spirit brands in its drinks cabinet. Meanwhile, Glaxo is a leading pharmaceutical company, which manufactures a broad selection of every day treatments and consumer goods that have become consumer staples over the years.

So, Diageo and Glaxo are not going to go out of business any time and it’s highly unlikely that either company will see its share price go to zero. 

With this being the case, investors can buy and hold the two companies’ shares in their portfolios over the long term without much worry. What’s more, both Glaxo and Diageo have a history of returning the majority of their earnings to investors in the form of dividends. Through the power of compounding, these cash returns have helped accelerate total returns achieved from the investments.

The power of compounding

If you invested £1,000 in Diageo during 1995, with dividends invested that stake would be worth £5,200 today, an average annual return of 10.10%. Similarly, if you’d purchased £1,000 of Glaxo stock during 1995, that stake would be worth £4,412 today, after achieving an average annual return of 7.9%. 

These figures may not seem like much at first glance, but for the long-term investor the returns really start to add up. Over four decades, a £1,000 investment in Glaxo, made during 1995 will be worth around £23,000 by 2035. However, the Diageo investment would worth a staggering £55,000 by 2035.

If you were to invest £1,000 in each company and add an additional £1,000 to each holding every year, based on the above rate of growth, your portfolio would be worth just under £1m by 2035.

Based on these numbers then, Glaxo and Diageo could make you a millionaire. 

Glaxo currently trades at a forward P/E of 17.3, which seems expensive but the company trades at a discount of about 10% to its international peers. The company’s shares offer a yield of 4.9%. Diageo currently trades at a forward P/E of 20.4, in line with its international peers and the company offers a dividend yield of 2.6%. 


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

7.5x earnings, £80.2m in net cash, and a big yield… what’s not to like about this UK stock?

This UK stock has a really strong net cash position relative to its size and its other metrics are very…

Read more »

Two male friends are out in Tynemouth, North East UK. They are walking on a sidewalk and pushing their baby sons in strollers. They are wearing warm clothing.
Investing For Beginners

My daughter could earn a £75,000 second income because we started an ISA at birth

Earning a second income is a dream for many Britons. By leveraging time, investors could make it a reality for…

Read more »

Portrait of a boy with the map of the world painted on his face.
Investing Articles

Could this trigger a stock market crash?

Dr James Fox takes a closer look at an alarming trend in the Far East that could have consequences for…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

What’s happening with the Jet2 share price?

The Jet2 share price has lost momentum after the tour operator said that customers were leaving their bookings to the…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

Could the Chancellor’s Leeds Reforms trigger a bull market for UK stocks?

More competitive lending and greater interest in shares could help kick start growth for UK businesses. But could it also…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

I think this AI stock could double before Palantir

Palantir stock is up almost 100% this year. As a result, it now sports a market cap of $350bn meaning…

Read more »

Elevated view over city of London skyline
Investing Articles

As the FTSE 100 hits an all-time high, is it time to reconsider the S&P 500?

Christopher Ruane explains why a surging FTSE 100 has not yet made him focus more on the potential of S&P…

Read more »

GSK scientist holding lab syringe
Investing Articles

The FTSE 100 sits at a record high. But some stocks still look dirt cheap!

The usually sluggish FTSE 100 is having a surprisingly good year. But our writer feels there are still potential bargains…

Read more »